Common data elements for preclinical epilepsy research

Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE

Lauren C. Harte-Hargrove, Jacqueline A. French, Asla Pitkänen, Aristea S. Galanopoulou, Vicky Whittemore, Helen E. Scharfman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The major objective of preclinical translational epilepsy research is to advance laboratory findings toward clinical application by testing potential treatments in animal models of seizures and epilepsy. Recently there has been a focus on the failure of preclinical discoveries to translate reliably, or even to be reproduced in different laboratories. One potential cause is a lack of standardization in preclinical data collection. The resulting difficulties in comparing data across studies have led to high cost and missed opportunity, which in turn impede clinical trials and advances in medical care. Preclinical epilepsy research has successfully brought numerous antiseizure treatments into the clinical practice, yet the unmet clinical needs have prompted the reconsideration of research strategies to optimize epilepsy therapy development. In the field of clinical epilepsy there have been successful steps to improve such problems, such as generation of common data elements (CDEs) and case report forms (CRFs and standards of data collection and reporting) by a team of leaders in the field. Therefore, the Translational Task Force was appointed by the International League Against Epilepsy (ILAE) and the American Epilepsy Society (AES), in partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) to define CDEs for animal epilepsy research studies and prepare guidelines for data collection and experimental procedures. If adopted, the preclinical CDEs could facilitate collaborative epilepsy research, comparisons of data across different laboratories, and promote rigor, transparency, and impact, particularly in therapy development.

Original languageEnglish (US)
Pages (from-to)78-86
Number of pages9
JournalEpilepsia
Volume58
DOIs
StatePublished - Nov 1 2017

Fingerprint

Advisory Committees
Epilepsy
Research Design
Research
National Institute of Neurological Disorders and Stroke
Translational Medical Research
Common Data Elements
National Institutes of Health (U.S.)
Seizures
Animal Models
Clinical Trials
Guidelines
Costs and Cost Analysis
Therapeutics

Keywords

  • Common data elements
  • Epilepsy
  • Guidelines
  • Preclinical
  • Standardization

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Common data elements for preclinical epilepsy research : Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE. / Harte-Hargrove, Lauren C.; French, Jacqueline A.; Pitkänen, Asla; Galanopoulou, Aristea S.; Whittemore, Vicky; Scharfman, Helen E.

In: Epilepsia, Vol. 58, 01.11.2017, p. 78-86.

Research output: Contribution to journalArticle

Harte-Hargrove, Lauren C. ; French, Jacqueline A. ; Pitkänen, Asla ; Galanopoulou, Aristea S. ; Whittemore, Vicky ; Scharfman, Helen E. / Common data elements for preclinical epilepsy research : Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE. In: Epilepsia. 2017 ; Vol. 58. pp. 78-86.
@article{a5dd0ef9ae004040866b1f6f8391ea6c,
title = "Common data elements for preclinical epilepsy research: Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE",
abstract = "The major objective of preclinical translational epilepsy research is to advance laboratory findings toward clinical application by testing potential treatments in animal models of seizures and epilepsy. Recently there has been a focus on the failure of preclinical discoveries to translate reliably, or even to be reproduced in different laboratories. One potential cause is a lack of standardization in preclinical data collection. The resulting difficulties in comparing data across studies have led to high cost and missed opportunity, which in turn impede clinical trials and advances in medical care. Preclinical epilepsy research has successfully brought numerous antiseizure treatments into the clinical practice, yet the unmet clinical needs have prompted the reconsideration of research strategies to optimize epilepsy therapy development. In the field of clinical epilepsy there have been successful steps to improve such problems, such as generation of common data elements (CDEs) and case report forms (CRFs and standards of data collection and reporting) by a team of leaders in the field. Therefore, the Translational Task Force was appointed by the International League Against Epilepsy (ILAE) and the American Epilepsy Society (AES), in partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) to define CDEs for animal epilepsy research studies and prepare guidelines for data collection and experimental procedures. If adopted, the preclinical CDEs could facilitate collaborative epilepsy research, comparisons of data across different laboratories, and promote rigor, transparency, and impact, particularly in therapy development.",
keywords = "Common data elements, Epilepsy, Guidelines, Preclinical, Standardization",
author = "Harte-Hargrove, {Lauren C.} and French, {Jacqueline A.} and Asla Pitk{\"a}nen and Galanopoulou, {Aristea S.} and Vicky Whittemore and Scharfman, {Helen E.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1111/epi.13906",
language = "English (US)",
volume = "58",
pages = "78--86",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Common data elements for preclinical epilepsy research

T2 - Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE

AU - Harte-Hargrove, Lauren C.

AU - French, Jacqueline A.

AU - Pitkänen, Asla

AU - Galanopoulou, Aristea S.

AU - Whittemore, Vicky

AU - Scharfman, Helen E.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - The major objective of preclinical translational epilepsy research is to advance laboratory findings toward clinical application by testing potential treatments in animal models of seizures and epilepsy. Recently there has been a focus on the failure of preclinical discoveries to translate reliably, or even to be reproduced in different laboratories. One potential cause is a lack of standardization in preclinical data collection. The resulting difficulties in comparing data across studies have led to high cost and missed opportunity, which in turn impede clinical trials and advances in medical care. Preclinical epilepsy research has successfully brought numerous antiseizure treatments into the clinical practice, yet the unmet clinical needs have prompted the reconsideration of research strategies to optimize epilepsy therapy development. In the field of clinical epilepsy there have been successful steps to improve such problems, such as generation of common data elements (CDEs) and case report forms (CRFs and standards of data collection and reporting) by a team of leaders in the field. Therefore, the Translational Task Force was appointed by the International League Against Epilepsy (ILAE) and the American Epilepsy Society (AES), in partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) to define CDEs for animal epilepsy research studies and prepare guidelines for data collection and experimental procedures. If adopted, the preclinical CDEs could facilitate collaborative epilepsy research, comparisons of data across different laboratories, and promote rigor, transparency, and impact, particularly in therapy development.

AB - The major objective of preclinical translational epilepsy research is to advance laboratory findings toward clinical application by testing potential treatments in animal models of seizures and epilepsy. Recently there has been a focus on the failure of preclinical discoveries to translate reliably, or even to be reproduced in different laboratories. One potential cause is a lack of standardization in preclinical data collection. The resulting difficulties in comparing data across studies have led to high cost and missed opportunity, which in turn impede clinical trials and advances in medical care. Preclinical epilepsy research has successfully brought numerous antiseizure treatments into the clinical practice, yet the unmet clinical needs have prompted the reconsideration of research strategies to optimize epilepsy therapy development. In the field of clinical epilepsy there have been successful steps to improve such problems, such as generation of common data elements (CDEs) and case report forms (CRFs and standards of data collection and reporting) by a team of leaders in the field. Therefore, the Translational Task Force was appointed by the International League Against Epilepsy (ILAE) and the American Epilepsy Society (AES), in partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) to define CDEs for animal epilepsy research studies and prepare guidelines for data collection and experimental procedures. If adopted, the preclinical CDEs could facilitate collaborative epilepsy research, comparisons of data across different laboratories, and promote rigor, transparency, and impact, particularly in therapy development.

KW - Common data elements

KW - Epilepsy

KW - Guidelines

KW - Preclinical

KW - Standardization

UR - http://www.scopus.com/inward/record.url?scp=85033396246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033396246&partnerID=8YFLogxK

U2 - 10.1111/epi.13906

DO - 10.1111/epi.13906

M3 - Article

VL - 58

SP - 78

EP - 86

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

ER -